glp-1 agonists reduce inflammation Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation: Cell Metabolism GLP-1 Receptor Agonists in the

2019;149:e59833

Some patients report no noticeable change

Improved Fat Utilisation: L-Carnitine encourages your body to burn stored fat instead of carbohydrates, which will help with long-term fat loss

Pancreas GLP-1 and GIP stimulate insulin secretion GLP-1 suppresses glucagon secretion during hyperglycemia GIP suppresses glucagon secretion during hyperglycemia and stimulates secretion during euglycemia and hypoglycemia Brain GLP-1 and GIP suppress hunger Stomach GLP-1 slows gastric emptying Fat tissue GIP increases fatty acid and glucose uptake by fat tissue [1,2,3] Tirzepatide Tirzepatide is a dual GLP-1 / GIP receptor agonist that mimics the actions of GLP-1 and GIP

Zalachoras, I., Hollis, F., Ramos-Fernndez, E., Trovo, L., Sonnay, S., Geiser, E., Preitner, N., Steiner, P., Sandi, C., & Morat, L